CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease
American Journal of Physiology-Cell Physiology · 2023
DOI: 10.1152/ajpcell.00144.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2023. Verfasst von Xiangyu Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology & Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Nephropathies. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Key-Area Research and development Program of Guangdong Province, Basic and Application Base Research Project of Guangzhou Basic Research Plan, President Foundation of Nanfang Hospital, the Southern Medical University.
Abstract (Originalsprache)
This article addresses the roles of ceramide synthase 6 ( CERS6) and CERS6-derived ceramides in renal tubular epithelial cells of diabetic kidney disease (DKD) associated interstitial fibrosis. Results from knockdown of CERS6 adjusted the ceramide pool in kidney cortex and markedly protected from diabetic-induced kidney fibrosis in vivo and in vitro. Mechanically, CERS6-derived ceramides might interact with PINK1 to inhibit PINK1/Parkin-mediated mitophagy and aggravate renal interstitial fibrosis in DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology & Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
- Division of Orthopaedic Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
- Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
- Central Laboratory, Southern Medical University, Guangzhou, People's Republic of China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Southern Medical University, Guangzhou, People's Republic…
ORCID-Profile: Xiangyu Wang, Yaoming Xue
Förderung
- Key-Area Research and development Program of Guangdong Province
- Basic and Application Base Research Project of Guangzhou Basic Research Plan
- President Foundation of Nanfang Hospital, the Southern Medical University
- GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province
- MOST | National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Wang, X., Song, M., Li, X., Su, C., Yang, Y., Wang, K., Liu, C., Zheng, Z., Jia, Y., Ren, S., Dong, W., Chen, J., Wang, T., Liu, L., Guan, M., Zhang, C., & Xue, Y. (2023). CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00144.2023
Vancouver
Wang X, Song M, Li X, Su C, Yang Y, Wang K, et al. CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease. American Journal of Physiology-Cell Physiology. 2023. doi:10.1152/ajpcell.00144.2023
BibTeX
@article{Wang2023,
author = {Wang, Xiangyu and Song, Minkai and Li, Xiaomin and Su, Cailin and Yang, Yanlin and Wang, Kai and Liu, Cuiting and Zheng, Zongji and Jia, Yijie and Ren, Shijing and Dong, Wenhui and Chen, Jiaqi and Wang, Ting and Liu, Lerong and Guan, Meiping and Zhang, Chao and Xue, Yaoming},
title = {CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease},
journal = {American Journal of Physiology-Cell Physiology},
year = {2023},
doi = {10.1152/ajpcell.00144.2023}
}
EUVIMED